Cambrian BioPharma Inc — Form D
Cambrian BioPharma Inc of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-15. The offering totals $129.8M, of which $123.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-07-15
- Form: D
- Accession: 0000950172-26-000183
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $129.8M
- Amount sold: $123.8M
- Remaining: $6.0M
- Investors: 80
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-590950
Issuer
- Name: Cambrian BioPharma Inc
- CIK: 0001797409
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 228 Park Avenue South Suite 66643, NEW YORK, NY, 10003
- Phone: (516) 962-3186
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Christian Angermeyer | Related Person | Birkirkara, O1 |
| William DeVaul | Related Person | New York, NY |
| Paul Farr | Related Person | Santa Monica, CA |
| Martin Gunhaga | Related Person | Umea, V7 |
| Juliette Han | Related Person | New York, NY |
| Mark Nuttall | Related Person | New York, NY |
| James Peyer | Related Person | New York, NY |
| Maryanna Saenko | Related Person | Los Altos, CA |
| Brenton L. Saunders | Related Person | Bridgewater, NJ |
| Ruth Thieroff-Ekerdt | Related Person | New York, NY |
| Lorin Van Nuland | Related Person | Birkirkara, O1 |
| Christian G Angermayer | Director | New York, NY |
| Maryanna G Saenko | Director | New York, NY |
| Paul G Farr | Director | New York, NY |
| James G Peyer | Director | New York, NY |
| James G Peyer | Executive Officer | New York, NY |
| James G Peyer | Promoter | New York, NY |
| Brenton G Saunders | Director | New York, NY |
| Christian G Angermeyer | Director | New York, NY |
Other filings by this issuer (5)
More